Mary Newman, SVP, Regulatory Affairs at Audentes Therapeutics, Inc. (BOLD), sold 19,600 shares at $30.79 ($595K) on 2018-03-15, disclosed to the SEC on 2018-04-02.
Open-market sale of $595k BOLD by SVP, Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.66 | 4,076 | $121K | 20.3% |
| 2 | $29.66 | 4,076 | $121K | 20.3% |
| 3 | $30.79 | 5,524 | $170K | 28.6% |
| 4 | $30.79 | 5,524 | $170K | 28.6% |
| 5 | $31.62 | 400 | $13K | 2.1% |
| Total | $30.34 avg | 19,600 |
| $595K |
| 100% |
| Filing → |
| BOLD | SELL | 2017-08-25 | $200K | — | Filing → |